ID
32066
Beschreibung
Study ID: 103992 Clinical Study ID: 103992 Study Title: Evaluate immunogenicity, reactogenicity & safety of 2 doses of GSK Biologicals’ oral live attenuated HRV vaccine (RIX4414 at 106.5 CCID50) when given concomitantly with OPV versus given alone (HRV vaccine dose given 15 days after the OPV dose) in healthy infants in Bangladesh Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00139334 https://clinicaltrials.gov/ct2/show/NCT00139334 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: Rotavirus Vaccine Trade Name: Rotarix Study Indication: Haemophilus influenzae type b; Neisseria Meningitidis This form is for documentation of study continuation and reasons for non continuation. To be checked at each visit from visit 2 onward. Visit 2 -> Timing: Day 30, Age: 10 weeks +/- 1 week (one item less) Visit 3 -> Timing: Day 45, Age: 12 weeks +/- 1 week Visit 4 -> Timing: Day 60, Age: 14 weeks +/- 1 week Visit 5 -> Timing: Day 75, Age: 16 weeks +/- 1 week Visit 6 -> Timing: Day 105, Age: 20 weeks +/- 1 week
Link
https://clinicaltrials.gov/ct2/show/NCT00139334
Stichworte
Versionen (1)
- 16.10.18 16.10.18 - Sarah Riepenhausen
Rechteinhaber
GlaxoSmithKline
Hochgeladen am
16. Oktober 2018
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY-NC 3.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
GSK Biologicals' oral HRV vaccine given with OPV in infants NCT00139334
Study Continuation
- StudyEvent: ODM
Beschreibung
Check for study continuation
Alias
- UMLS CUI-1
- C0805733
- UMLS CUI-2
- C0008976
- UMLS CUI-3
- C0042210
Beschreibung
if yes: please complete all necessary forms for this visit. if no: please complete the rest of the items of this form.
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0805733
Beschreibung
if yes, you can skip the following item. This is only applicable from Visit 3 onward (not applicable for visit 2).
Datentyp
boolean
Alias
- UMLS CUI [1,1]
- C0457454
- UMLS CUI [1,2]
- C0566251
Beschreibung
Reason for discontinuation
Datentyp
text
Alias
- UMLS CUI [1,1]
- C0457454
- UMLS CUI [1,2]
- C0566251
Beschreibung
If the most appropriate reason for discontinuation is a serious adverse event, please specify SAE No. and complete SAE form.
Datentyp
text
Alias
- UMLS CUI [1,1]
- C1519255
- UMLS CUI [1,2]
- C0237753
Beschreibung
If the most appropriate reason for discontinuation is a non-serious adverse event (unsolicited), please specify unsolicited AE No. and complete Non-serious Adverse Event form. If solicited AE, please complete the solicited adverse event code item instead.
Datentyp
integer
Alias
- UMLS CUI [1,1]
- C4055646
- UMLS CUI [1,2]
- C1518404
- UMLS CUI [1,3]
- C0237753
Beschreibung
If the most appropriate reason for discontinuation is a non-serious adverse event (solicited), please specify solicited AE code and complete solicited Non-serious Adverse Event form. If unsolicited non-serious adverse event, please complete the Unsoliceted AE number item.
Datentyp
integer
Alias
- UMLS CUI [1,1]
- C1517001
- UMLS CUI [1,2]
- C1518404
- UMLS CUI [1,3]
- C0237753
Beschreibung
If the reason is not an adverse event, please specify, e.g. consent withdrawal protocol violation, ...
Datentyp
text
Alias
- UMLS CUI [1]
- C3840932
Beschreibung
Person deciding about discontinuation
Datentyp
text
Alias
- UMLS CUI [1,1]
- C0679006
- UMLS CUI [1,2]
- C0457454
Ähnliche Modelle
Study Continuation
- StudyEvent: ODM
C0008976 (UMLS CUI-2)
C0042210 (UMLS CUI-3)
C0566251 (UMLS CUI [1,2])
C0566251 (UMLS CUI [1,2])
C0237753 (UMLS CUI [1,2])
C1518404 (UMLS CUI [1,2])
C0237753 (UMLS CUI [1,3])
C1518404 (UMLS CUI [1,2])
C0237753 (UMLS CUI [1,3])
C0457454 (UMLS CUI [1,2])